Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-28

FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) from Endo USA, Inc., marking an approved update to its labeling or in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

SUPPL AP for XIAFLEX (COLLAGENASE CLOSTRIDIUM HISTOLYTICUM)